Repro-Med Systems, Inc. (OTCMKTS:REPR) Director Joseph M. Jr. Manko purchased 137,225 shares of Repro-Med Systems stock in a transaction on Tuesday, December 12th. The stock was bought at an average cost of $0.90 per share, with a total value of $123,502.50. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Shares of Repro-Med Systems, Inc. (OTCMKTS REPR) remained flat at $$0.90 during mid-day trading on Tuesday. 121,749 shares of the company’s stock traded hands, compared to its average volume of 59,071. Repro-Med Systems, Inc. has a twelve month low of $0.34 and a twelve month high of $0.92. The company has a market cap of $34.05, a price-to-earnings ratio of 88.00 and a beta of -0.59.

WARNING: This piece was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international trademark and copyright law. The legal version of this piece can be read at https://www.americanbankingnews.com/2017/12/12/repro-med-systems-inc-repr-director-joseph-m-jr-manko-acquires-137225-shares.html.

About Repro-Med Systems

REPRO MED SYSTEMS, INC. (RMS) designs, manufactures and markets medical devices for the ambulatory infusion market and emergency medical applications. The Company’s products include FREEDOM60 Syringe Infusion System (FREEDOM60), RMS HIGH-Flo Subcutaneous Safety Needle Sets (HIgH-Flo), RES-Q-VAC Portable Medical Suction System (RES-Q-VAC) and On-Line Calculator.

Insider Buying and Selling by Quarter for Repro-Med Systems (OTCMKTS:REPR)

Receive News & Ratings for Repro-Med Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repro-Med Systems and related companies with MarketBeat.com's FREE daily email newsletter.